Elberry, Dalia AzmyAmin, Shaimaa NasrEsmail, Reham Shehab El NemrRashed, Laila AhmedGamal, Maha Mohamed2017-02-142017-02-142016-11-071611-2156http://hdl.handle.net/2003/3581210.17877/DE290R-17836Liver cirrhosis is the outcome of chronic liver injury. The current study aimed to investigate the therapeutic effect of undifferentiated mesenchymal stem cells versus in vitro partially differentiated mesenchymal stem cells on liver cirrhosis and hepatic encephalopathy. 50 adult male albino rats constituted the animal model and were divided into the following groups: control, thioacetamide, undifferentiated mesenchymal stem cells and hepatocyte growth factor-differentiated mesenchymal stem cells groups. Cognitive assessment was achieved by open field test and Y-maze task. We measured serum alanine aminotransferase, albumin and transforming growth factor-beta1, gene expression of α-smooth muscle actin, matrix metalloprotein-2, its tissue inhibitor and apoptotic markers: Bax and Bcl2, brain glial fibrillary acidic protein, synaptophysin, and dopaminergic receptors.enEXCLI Journal;Vol. 15, 2016https://creativecommons.org/licenses/by/4.0/liverhepatic encephalopathystem cellshippocampusbasal ganglia61010.17179/excli2016-645article (journal)